Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents

J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.10.011. Epub 2021 Oct 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibody Formation
  • BNT162 Vaccine
  • COVID-19* / prevention & control
  • Humans
  • Nursing Homes
  • RNA, Messenger
  • SARS-CoV-2* / genetics
  • Vaccination

Substances

  • RNA, Messenger
  • BNT162 Vaccine